Key result
Cholesterol-lowering strategies show significant potential for preventing coronary heart disease.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Scott M. Grundy (1986) conducted a review in Coronary Heart Disease. Cholesterol-lowering therapies (bile acid sequestrants, HMG-CoA reductase inhibitors) was evaluated. Cholesterol-lowering strategies, including bile acid sequestrants and new HMG-CoA reductase inhibitors, demonstrate significant potential for the prevention of coronary heart disease.
Synapse has enriched 10 related papers. Consider them for comparative context: